Header Logo

Connection

Bavesh Kana to Humans

Back to Details
This is a "connection" page, showing publications Bavesh Kana has written about Humans.
Bavesh Kana
Connection Strength
1,693
Humans
  1. A modified BCG with depletion of enzymes associated with peptidoglycan amidation induces enhanced protection against tuberculosis in mice. Elife. 2024 Apr 19; 13.
    View in: PubMed
    Score: 0,070
  2. Development of primer-probe sets to rapidly distinguish single nucleotide polymorphisms in SARS-CoV-2 lineages. Front Cell Infect Microbiol. 2023; 13:1283328.
    View in: PubMed
    Score: 0,068
  3. Production and Performance Assessment of a Severe Acute Respiratory Syndrome Coronavirus 2 Biomimetic in a Verification Program for Pandemic Readiness. J Mol Diagn. 2023 12; 25(12):907-912.
    View in: PubMed
    Score: 0,067
  4. Evaluation of a human mucosal tissue explant model for SARS-CoV-2 replication. PLoS One. 2023; 18(9):e0291146.
    View in: PubMed
    Score: 0,067
  5. The performance of tongue swabs for detection of pulmonary tuberculosis. Front Cell Infect Microbiol. 2023; 13:1186191.
    View in: PubMed
    Score: 0,067
  6. Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa. Lancet Infect Dis. 2023 08; 23(8):e288-e300.
    View in: PubMed
    Score: 0,065
  7. Differentially culturable tubercle bacteria as a measure of tuberculosis treatment response. Front Cell Infect Microbiol. 2022; 12:1064148.
    View in: PubMed
    Score: 0,064
  8. The detection of mixed tuberculosis infections using culture filtrate and resuscitation promoting factor deficient filtrate. Front Cell Infect Microbiol. 2022; 12:1072073.
    View in: PubMed
    Score: 0,063
  9. Survival and detection of SARS-CoV-2 variants on dry swabs post storage. Front Cell Infect Microbiol. 2022; 12:1031775.
    View in: PubMed
    Score: 0,063
  10. Drug resistant tuberculosis: Implications for transmission, diagnosis, and disease management. Front Cell Infect Microbiol. 2022; 12:943545.
    View in: PubMed
    Score: 0,062
  11. Detection of differentially culturable tubercle bacteria in sputum from drug-resistant tuberculosis patients. Front Cell Infect Microbiol. 2022; 12:949370.
    View in: PubMed
    Score: 0,062
  12. Detection of Mycobacterium tuberculosis Complex Bacilli and Nucleic Acids From Tongue Swabs in Young, Hospitalized Children. Front Cell Infect Microbiol. 2021; 11:696379.
    View in: PubMed
    Score: 0,057
  13. Supplementation of sputum cultures with culture filtrate to detect tuberculosis in a cross-sectional study of HIV-infected individuals. Tuberculosis (Edinb). 2021 07; 129:102103.
    View in: PubMed
    Score: 0,057
  14. Detection of differentially culturable tubercle bacteria in sputum using mycobacterial culture filtrates. Sci Rep. 2021 03 22; 11(1):6493.
    View in: PubMed
    Score: 0,056
  15. Cell Surface Biosynthesis and Remodeling Pathways in Mycobacteria Reveal New Drug Targets. Front Cell Infect Microbiol. 2020; 10:603382.
    View in: PubMed
    Score: 0,055
  16. Genetic Diversity in Mycobacterium tuberculosis Clinical Isolates and Resulting Outcomes of Tuberculosis Infection and Disease. Annu Rev Genet. 2020 11 23; 54:511-537.
    View in: PubMed
    Score: 0,054
  17. Application of model systems to study adaptive responses of Mycobacterium tuberculosis during infection and disease. Adv Appl Microbiol. 2019; 108:115-161.
    View in: PubMed
    Score: 0,050
  18. Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings. Lancet Infect Dis. 2019 03; 19(3):e65-e76.
    View in: PubMed
    Score: 0,048
  19. ß-lactam resistance: The role of low molecular weight penicillin binding proteins, ß-lactamases and ld-transpeptidases in bacteria associated with respiratory tract infections. IUBMB Life. 2018 09; 70(9):855-868.
    View in: PubMed
    Score: 0,046
  20. Genetic Mimetics of Mycobacterium tuberculosis and Methicillin-Resistant Staphylococcus aureus as Verification Standards for Molecular Diagnostics. J Clin Microbiol. 2017 12; 55(12):3384-3394.
    View in: PubMed
    Score: 0,044
  21. Relapse, re-infection and mixed infections in tuberculosis disease. Pathog Dis. 2017 Apr 01; 75(3).
    View in: PubMed
    Score: 0,043
  22. Detection and Quantification of Differentially Culturable Tubercle Bacteria in Sputum from Patients with Tuberculosis. Am J Respir Crit Care Med. 2016 12 15; 194(12):1532-1540.
    View in: PubMed
    Score: 0,042
  23. Future target-based drug discovery for tuberculosis? Tuberculosis (Edinb). 2014 Dec; 94(6):551-6.
    View in: PubMed
    Score: 0,036
  24. bis-Molybdopterin guanine dinucleotide is required for persistence of Mycobacterium tuberculosis in guinea pigs. Infect Immun. 2015 Feb; 83(2):544-50.
    View in: PubMed
    Score: 0,036
  25. Comparative genomics for mycobacterial peptidoglycan remodelling enzymes reveals extensive genetic multiplicity. BMC Microbiol. 2014 Mar 24; 14:75.
    View in: PubMed
    Score: 0,035
  26. Depletion of resuscitation-promoting factors has limited impact on the drug susceptibility of Mycobacterium tuberculosis. J Antimicrob Chemother. 2010 Aug; 65(8):1583-5.
    View in: PubMed
    Score: 0,027
  27. Role of the DinB homologs Rv1537 and Rv3056 in Mycobacterium tuberculosis. J Bacteriol. 2010 Apr; 192(8):2220-7.
    View in: PubMed
    Score: 0,026
  28. Resuscitation-promoting factors as lytic enzymes for bacterial growth and signaling. FEMS Immunol Med Microbiol. 2010 Feb; 58(1):39-50.
    View in: PubMed
    Score: 0,025
  29. The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro. Mol Microbiol. 2008 Feb; 67(3):672-84.
    View in: PubMed
    Score: 0,023
  30. The effect of previous SARS-CoV-2 infection on systemic immune responses in individuals with tuberculosis. Front Immunol. 2024; 15:1357360.
    View in: PubMed
    Score: 0,018
  31. Molecular genetics of Mycobacterium tuberculosis in relation to the discovery of novel drugs and vaccines. Tuberculosis (Edinb). 2004; 84(1-2):63-75.
    View in: PubMed
    Score: 0,017
  32. Culture filtrate supplementation can be used to improve Mycobacterium tuberculosis culture positivity for spinal tuberculosis diagnosis. Front Cell Infect Microbiol. 2022; 12:1065893.
    View in: PubMed
    Score: 0,016
  33. Comparing rates of mycobacterial clearance in sputum smear-negative and smear-positive adults living with HIV. BMC Infect Dis. 2021 May 22; 21(1):466.
    View in: PubMed
    Score: 0,014
  34. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa. S Afr Med J. 2020 12 14; 0(0):13163.
    View in: PubMed
    Score: 0,014
  35. The Scientists' Collective 10-point proposal for equitable and timeous access to COVID-19 vaccine in South Africa. S Afr Med J. 2020 12 14; 111(2):89-94.
    View in: PubMed
    Score: 0,014
  36. Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy. Front Cell Infect Microbiol. 2020; 10:443.
    View in: PubMed
    Score: 0,014
  37. Remembering the Host in Tuberculosis Drug Development. J Infect Dis. 2019 04 19; 219(10):1518-1524.
    View in: PubMed
    Score: 0,012
  38. Moving toward Tuberculosis Elimination. Critical Issues for Research in Diagnostics and Therapeutics for Tuberculosis Infection. Am J Respir Crit Care Med. 2019 03 01; 199(5):564-571.
    View in: PubMed
    Score: 0,012
  39. Rapid detection of Mycobacterium tuberculosis in sputum with a solvatochromic trehalose probe. Sci Transl Med. 2018 02 28; 10(430).
    View in: PubMed
    Score: 0,011
  40. Getting to Zero New Tuberculosis Infections: Insights From the National Institutes of Health/US Centers for Disease Control and Prevention/Bill & Melinda Gates Foundation Workshop on Research Needs for Halting Tuberculosis Transmission. J Infect Dis. 2017 11 03; 216(suppl_6):S627-S628.
    View in: PubMed
    Score: 0,011
  41. Pulmonary TB: varying radiological presentations in individuals with HIV in Soweto, South Africa. Trans R Soc Trop Med Hyg. 2017 03 01; 111(3):132-136.
    View in: PubMed
    Score: 0,011
  42. Activity of phosphino palladium(II) and platinum(II) complexes against HIV-1 and Mycobacterium tuberculosis. Biometals. 2016 08; 29(4):637-50.
    View in: PubMed
    Score: 0,010
  43. The contribution of Nth and Nei DNA glycosylases to mutagenesis in Mycobacterium smegmatis. DNA Repair (Amst). 2014 Jan; 13:32-41.
    View in: PubMed
    Score: 0,008
  44. Performance monitoring of mycobacterium tuberculosis dried culture spots for use with the GeneXpert system within a national program in South Africa. J Clin Microbiol. 2013 Dec; 51(12):4018-21.
    View in: PubMed
    Score: 0,008
  45. Perturbation of cytochrome c maturation reveals adaptability of the respiratory chain in Mycobacterium tuberculosis. mBio. 2013 Sep 17; 4(5):e00475-13.
    View in: PubMed
    Score: 0,008
  46. Dried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa. J Clin Microbiol. 2011 Dec; 49(12):4356-60.
    View in: PubMed
    Score: 0,007
  47. The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect Immun. 2008 Jul; 76(7):3027-36.
    View in: PubMed
    Score: 0,006
  48. Heat shock cognate protein 70 chaperone-binding site in the co-chaperone murine stress-inducible protein 1 maps to within three consecutive tetratricopeptide repeat motifs. Biochem J. 2000 Feb 01; 345 Pt 3:645-51.
    View in: PubMed
    Score: 0,003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.